Offstream
news

Georgia receives 43,200 doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
2021-07-10

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford.
2021-04-20

Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
2021-03-22

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

The World Health Organization announces the approval of the Oxford–AstraZeneca vaccine.
2021-02-15

AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2.
2021-02-5

South Africa approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

Brazil begins distribution of the AstraZeneca-Oxford University vaccine.
2021-01-23

India approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca, becoming the third country in the world to do so after the United Kingdom and Argentina.
2021-01-1